Dr Reddys Laboratories Share Price Today - Live Blog for May 06, 2025

With a -0.24% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,158.15. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.2200, while the industry PE is 34.3056.

The share price of Dr Reddys Laboratories Ltd plunged by -0.26%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,159.00, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.26% boost, with the current market value at ₹1,161.90 per share. This surge has not gone unnoticed by investors.

With a -0.17% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,159.00. Investors should examine the factors driving this decline. The stock's PE ratio is 18.2200, whereas the industry PE ratio stands at 34.3056.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% drop, and it's now trading at ₹1,161.25 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's share price has fallen by -0.09%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,161.50, and market participants are assessing the implications. The stock has a PE ratio of 18.2200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

With a -0.00% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,162.45. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.2200, while the industry PE is 34.3056.

Dr Reddys Laboratories Ltd experienced a -0.11% downturn in its share price, and it's currently trading at ₹1,162.45. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.09% uptick in its share price. As a result, it's now actively trading at ₹1,163.75 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.09%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,162.10, and market participants are assessing the implications. The stock has a PE ratio of 18.2200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The stock of Dr Reddys Laboratories Ltd suffered a -0.21% decline, and it currently trades at ₹1,163.65 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd plunged by -0.18%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,167.40, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd experienced a -0.05% slump and is currently trading at ₹1,170.35. While the stock maintains a PE ratio of 18.2200, the industry PE is 34.3056, raising questions about valuation.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.21%, reaching the current market price of ₹1,170.40. This development underscores the stock's growing popularity.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.06% recently. As of now, this stock is actively trading at a current market price of ₹1,168.15 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.02% uptick in its share price. As a result, it's now actively trading at ₹1,166.75 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.06%, and it is currently trading at ₹1,165.75. Additionally, the stock maintains a PE ratio of 18.2200, while the industry PE is 34.3056.

With a remarkable 0.22% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,165.05. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.2200, while the industry's PE ratio is 34.3056.

The stock of Dr Reddys Laboratories Ltd suffered a -0.25% decline, and it currently trades at ₹1,162.55 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.08% uptick in its share price. As a result, it's now actively trading at ₹1,165.75 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's stock price surged by 0.48%, reaching the current market value of ₹1,165.90 per share. This surge is a testament to the stock's recent performance.

Demonstrating a commendable 0.01% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,160.00. In terms of valuation, the stock maintains a PE ratio of 18.2200, while the industry PE ratio stands at 34.3056.

Dr Reddys Laboratories Ltd witnessed a substantial 0.42% increase in its share price and is currently trading at ₹1,159.75. This remarkable performance has caught the eye of investors.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.07% increase. Presently, it is actively trading at ₹1,154.85.

Dr Reddys Laboratories Ltd experienced a -0.24% downturn in its share price, and it's currently trading at ₹1,157.20. This situation is generating interest among value investors who are evaluating the stock's potential.

The stock of Dr Reddys Laboratories Ltd suffered a -0.24% drop, and it's now trading at ₹1,157.20 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.